Theratechnologies Inc. (THTX)
USD 2.57
(32.47%)
USD 2.57
(32.47%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 51.26 Million USD | 3445.02% |
| 2022 | 1.44 Million USD | -97.43% |
| 2021 | 56.28 Million USD | 2.41% |
| 2020 | 54.95 Million USD | 8.31% |
| 2019 | 50.74 Million USD | 4.35% |
| 2018 | 48.62 Million USD | 1278.91% |
| 2017 | 3.52 Million USD | -46.74% |
| 2016 | 6.62 Million USD | -29.5% |
| 2015 | 9.39 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 45.83 Million USD | -9.46% |
| 2024 Q3 | 36.24 Million USD | -11.76% |
| 2024 Q2 | 41.07 Million USD | -10.5% |
| 2023 Q3 | 684 Thousand USD | -98.24% |
| 2023 Q1 | 38.54 Million USD | 2565.7% |
| 2023 Q4 | 51.26 Million USD | 7394.3% |
| 2023 FY | 51.26 Million USD | 3445.02% |
| 2023 Q2 | 38.9 Million USD | 0.92% |
| 2022 Q2 | 55.2 Million USD | 0.92% |
| 2022 Q4 | 1.44 Million USD | -96.32% |
| 2022 Q3 | 39.32 Million USD | -28.77% |
| 2022 FY | 1.44 Million USD | -97.43% |
| 2022 Q1 | 54.7 Million USD | 0.87% |
| 2021 FY | 56.28 Million USD | 2.41% |
| 2021 Q3 | 53.75 Million USD | 0.87% |
| 2021 Q1 | 52.83 Million USD | 0.82% |
| 2021 Q4 | 54.22 Million USD | 0.88% |
| 2021 Q2 | 53.29 Million USD | 0.86% |
| 2020 Q1 | 51.13 Million USD | 0.77% |
| 2020 FY | 54.95 Million USD | 8.31% |
| 2020 Q2 | 51.55 Million USD | 0.82% |
| 2020 Q3 | 51.97 Million USD | 0.81% |
| 2020 Q4 | 52.4 Million USD | 0.83% |
| 2019 Q3 | 50.34 Million USD | 0.76% |
| 2019 Q1 | 49.59 Million USD | 0.73% |
| 2019 Q2 | 49.96 Million USD | 0.76% |
| 2019 FY | 50.74 Million USD | 4.35% |
| 2019 Q4 | 50.74 Million USD | 0.78% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | 48.62 Million USD | 1278.91% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | 49.23 Million USD | 0.97% |
| 2018 Q3 | 48.76 Million USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | 3.52 Million USD | -46.74% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | 6.62 Million USD | -29.5% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | 9.39 Million USD | 0.0% |
| 2015 Q2 | - USD | -100.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q1 | 15.82 Million USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q1 | - USD | -100.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1998 Q2 | 68.65 Thousand USD | 0.0% |
| 1998 Q3 | 63.27 Thousand USD | -7.83% |
| 1998 Q4 | 65.1 Thousand USD | 2.89% |
| 1998 Q1 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 89.538% |
| Embecta Corp. | 1.62 Billion USD | 96.846% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 83.447% |
| Dynavax Technologies Corporation | 252.41 Million USD | 79.692% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 89.779% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 90.023% |
| PainReform Ltd. | 30 Thousand USD | -170770.0% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | 43.716% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -9409.772% |
| SCYNEXIS, Inc. | 12.15 Million USD | -321.589% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -43664.567% |
| Cosmos Health Inc. | 3.03 Million USD | -1588.805% |
| Journey Medical Corporation | 14.62 Million USD | -250.574% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -9409.772% |
| Safety Shot Inc | 304.9 Thousand USD | -16712.012% |
| Alpha Teknova, Inc. | 13.25 Million USD | -286.846% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | -284.669% |
| Bright Green Corporation | 201.78 Thousand USD | -25304.023% |
| Procaps Group, S.A. | 28.41 Million USD | -80.433% |
| Harrow Health, Inc. | 183.17 Million USD | 72.015% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -58820.69% |
| Biofrontera Inc. | 804 Thousand USD | -6275.746% |
| DURECT Corporation | 2.7 Million USD | -1797.15% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | -54.419% |
| Cronos Group Inc. | 1.55 Million USD | -3188.069% |
| OptiNose, Inc. | 611 Thousand USD | -8289.689% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 89.713% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | -49.93% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -11166.154% |
| Organogenesis Holdings Inc. | 60.74 Million USD | 15.613% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -300.973% |
| Radius Health, Inc. | 339.66 Million USD | 84.908% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | -399.717% |
| Phibro Animal Health Corporation | 458.28 Million USD | 88.815% |
| Procaps Group S.A. | 28.41 Million USD | -80.433% |
| Alvotech | 1.02 Billion USD | 95.012% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -684.767% |
| Viatris Inc. | 16.18 Billion USD | 99.683% |
| Rockwell Medical, Inc. | 8.29 Million USD | -518.124% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -371.279% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -15156.659% |
| Tilray Brands, Inc. | 287.93 Million USD | 82.197% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 57.463% |
| Shineco, Inc. | 10.01 Million USD | -411.723% |
| PetIQ, Inc. | 437.82 Million USD | 88.292% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -24310.0% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 80.154% |
| Alimera Sciences, Inc. | 64.48 Million USD | 20.512% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | -33.097% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -37846.095% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -647.532% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -7019.583% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -227888.792% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | -56.474% |
| Hempacco Co., Inc. | 5.93 Million USD | -764.289% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 95.012% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 8.814% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 91.68% |
| Currenc Group, Inc. | 2.5 Million USD | -1944.736% |
| Kamada Ltd. | 7.43 Million USD | -589.177% |
| Indivior PLC | 235.66 Million USD | 78.249% |
| Evoke Pharma, Inc. | 5 Million USD | -925.22% |
| Flora Growth Corp. | 942 Thousand USD | -5341.72% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -227888.792% |
| Evolus, Inc. | 120.35 Million USD | 57.41% |
| HUTCHMED (China) Limited | 48.18 Million USD | -6.375% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 91.3% |
| Akanda Corp. | 2.49 Million USD | -1952.776% |